文献速递认知障碍与痴呆

临床前阿尔茨海默病患者中皮层tau正电子发射断层扫描模式存在差异

Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.
PubMed 文献 · JAMA Neurol · 2022-01-01

这项横断面研究分析了A4研究447名临床未受损老年人的tau PET、淀粉样蛋白PET及认知数据,发现A+组中9%存在异质性皮层tau模式,30%为内侧颞叶tau升高;异质性皮层tau模式在ADNI、HABS和Wisconsin队列中表现一致。

要点

  • A+组中9%呈现异质性皮层tau模式,分为左侧不对称、楔前叶为主和右侧不对称三个亚型。
  • A+组中30%显示内侧颞叶tau升高(A+T MTL+)。
  • A+T cortical+组较A+T MTL+组年轻,执行功能评分更低,记忆评分相当。

核心结论

  • 本研究提示临床前阿尔茨海默病早期tau沉积可能遵循多种轨迹,并可能涉及多个皮层区域。
  • 基于神经病理学、假设个体间轨迹一致的分期方法不足以用于tau成像的疾病监测。

研究设计与样本

  • 横断面研究,分析A4研究2014年4月至2017年12月的随机化前tau PET、淀粉样蛋白PET、结构MRI、人口学和认知数据。
  • A4研究纳入447名临床未受损且具有淀粉样蛋白和tau PET数据的参与者(A+组392例,正常β-淀粉样蛋白组55例),平均(SD)年龄71.8(4.8)岁,女性239例(54%)。
  • 随访分析使用ADNI(n=433)、HABS(n=190)和Wisconsin(n=328)的观察性tau PET数据评估一致性。
  • 数据分析时间为2021年5月11日至2022年1月25日。

主要发现

  • A+组中36例(占A+组的9%)呈现异质性皮层tau模式,进一步分为左侧不对称、楔前叶为主和右侧不对称三个亚型。
  • A+组中116例(占A+组的30%)显示内侧颞叶tau升高(A+T MTL+)。
  • A+T cortical+组个体较A+T MTL+组年轻(t61.867=-2.597;P=.03)。
  • 在A+T cortical+组和A+T MTL+组中,区域tau增加与海马体积减小和内侧颞叶厚度减小相关,但与皮层厚度无关。
  • A+T cortical+组与A+T MTL+组记忆评分相当,而A+T cortical+组执行功能评分低于A+T MTL+组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Characterization of early tau deposition in individuals with preclinical Alzheimer disease (AD) is critical for prevention trials that aim to select individuals at risk for AD and halt the progression of disease. OBJECTIVE: To evaluate the prevalence of cortical tau positron emission tomography (PET) heterogeneity in a large cohort of clinically unimpaired older adults with elevated β-amyloid (A+). DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study examined prerandomized tau PET, amyloid PET, structural magnetic resonance imaging, demographic, and cognitive data from the Anti-Amyloid Treatment in Asymptomatic AD (A4) Study from April 2014 to December 2017. Follow-up analyses used observational tau PET data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), the Harvard Aging Brain Study (HABS), and the Wisconsin Registry for Alzheimer's Prevention and the Wisconsin Alzheimer's Disease Research Center (together hereinafter referred to as Wisconsin) to evaluate consistency. Participants were clinically unimpaired at the study visit closest to the tau PET scan and had available amyloid and tau PET data (A4 Study, n = 447; ADNI, n = 433; HABS, n = 190; and Wisconsin, n = 328). No participants who met eligibility criteria were excluded. Data were analyzed from May 11, 2021, to January 25, 2022. MAIN OUTCOMES AND MEASURES: Individuals with preclinical AD with heterogeneous cortical tau PET patterns (A+T cortical+) were identified by examining asymmetrical cortical tau signal and disproportionate cortical tau signal relative to medial temporal lobe (MTL) tau. Voxelwise tau patterns, amyloid, neurodegeneration, cognition, and demographic characteristics were examined. RESULTS: The 447 A4 participants (A+ group, 392; and normal β-amyloid group, 55), with a mean (SD) age of 71.8 (4.8) years, included 239 women (54%). A total of 36 individuals in the A+ group (9% of the A+ group) exhibited heterogeneous cortical tau patterns and were further categorized into 3 subtypes: asymmetrical left, precuneus dominant, and asymmetrical right. A total of 116 individuals in the A+ group (30% of the A+ group) showed elevated MTL tau (A+T MTL+). Individuals in the A+T cortical+ group were younger than those in the A+T MTL+ group (t61.867 = -2.597; P = .03). Across the A+T cortical+ and A+T MTL+ groups, increased regional tau was associated with reduced hippocampal volume and MTL thickness but not with cortical thickness. Memory scores were comparable between the A+T cortical+ and A+T MTL+ groups, whereas executive functioning scores were lower for the A+T cortical+ group than for the A+T MTL+ group. The prevalence of the A+T cortical+ group and tau patterns within the A+T cortical+ group were consistent in ADNI, HABS, and Wisconsin. CONCLUSIONS AND RELEVANCE: This study suggests that early tau deposition may follow multiple trajectories during preclinical AD and may involve several cortical regions. Staging procedures, especially those based on neuropathology, that assume a uniform trajectory across individuals are insufficient for disease monitoring with tau imaging.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Young CB, Winer JR, Younes K, et al. Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease. JAMA Neurol. 2022. PMID: 35435938. doi:10.1001/jamaneurol.2022.0676

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。